Showing results (21-30 of 99) with videos related to
Sort By:
Pageof 10
Best Practice & Research. Clinical Endocrinology & Metabolism|May 20, 2015
Non-neuronopathic lysosomal storage disorders: Disease spectrum and treatmentsGregory M Pastores, Derralynn A HughesWiener Medizinische Wochenschrift (1946)|January 12, 2011
The pathophysiology of GD - current understanding and rationale for existing and emerging therapeutic approachesDerralynn A Hughes, Gregory M PastoresCurrent Opinion in Rheumatology|December 18, 2004
Musculoskeletal complications associated with lysosomal storage disorders: Gaucher disease and Hurler-Scheie syndrome (mucopolysaccharidosis type I)Gregory M Pastores, Patrick A MeereExpert Opinion on Emerging Drugs|November 3, 2005
Current and emerging therapies for the lysosomal storage disordersGregory M Pastores, Natalie L BarnettBiologics : Targets & Therapy|October 24, 2009
A systematic review of new advances in the management of mucopolysaccharidosis VI (Maroteaux-Lamy syndrome): focus on galsulfaseRegina P El Dib, Gregory M PastoresThe Cochrane Database of Systematic Reviews|May 14, 2010
Enzyme replacement therapy for Anderson-Fabry diseaseRegina P El Dib, Gregory M PastoresNeurologic Clinics|November 2, 2013
Clinical neurogenetics: neuropathic lysosomal storage disordersGregory M Pastores, Gustavo H B MaegawaClinical Therapeutics|October 4, 2005
An open-label, noncomparative study of miglustat in type I Gaucher disease: efficacy and tolerability over 24 months of treatmentGregory M Pastores, Natalie L Barnett, Edwin H KolodnyClinical Therapeutics|October 9, 2007
Effect of miglustat on bone disease in adults with type 1 Gaucher disease: a pooled analysis of three multinational, open-label studiesGregory M Pastores, Deborah Elstein, Martin Hrebícek, et al.The Cochrane Database of Systematic Reviews|March 2, 2013
Enzyme replacement therapy for Anderson-Fabry diseaseRegina P El Dib, Paulo Nascimento, Gregory M PastoresPageof 10